Prevalence of diabetes mellitus and antidiabetic drug utilization in the Eastern Bosnia and Herzegovina: A pilot study-Reference-Cited by-同舟云学术

Prevalence of diabetes mellitus and antidiabetic drug utilization in the Eastern Bosnia and Herzegovina: A pilot study

Published:2018 Issue:3 Volume:5 Page:687-693
ISSN:2334-9492
Container-title:Hospital Pharmacology - International Multidisciplinary Journal
language:en
Short-container-title:Hosp Pharm Int Multi J

Author:

Popržen Jelena,Tomić Zdenko,Tomas Ana,Paut-Kusturica Milica,Sabo Ana,Horvat Olga

Funder

Ministry of Education, Science and Technological Development of the Republic of Serbia

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Subject

General Medicine

Link

https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2018/2334-94921803687P.pdf

Reference27 articles.

1. International Diabetes Federation. IDF DIABETES ATLAS. 6th ed. 2013.;

2. Murray, C. J. L., Lopez A.D., Vos t. et al. and GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990- 2013: quantifying the epidemiological transition. Lancet 2015; 386 (10009): 2145-91.;

3. Murray, C. J. L., Lopez A.D., Vos t. et al. and GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specifi c all-cause and cause-specifi c mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385(9963):117-71.;

4. Institute for Health Meatrics and Evaluation, document available on http://www.healthdata. org/bosnia-and-herzegovina;

5. Agency for Statistics of Bosnia and Herzegovina. Census of Population, Households and Dwellings in Bosnia and Herzegovina, 2013 fi nal results. Sarajevo: Agency for Statistics of Bosnia and Herzegovina; 2016. Available at: http://www.popis2013.ba/popis2013/doc/Popis2013prvoIzdanje.pdf [Accessed 28 Nov, 2016];